Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-10-31
1988-07-19
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514333, 514338, 514343, 546193, 546194, 546256, 546270, 546281, A61K 3144, A61K 31445, C07D40112, C07D40114
Patent
active
047585765
ABSTRACT:
This invention relates to 2-pyridine derivatives substituted in the 4-position with a dialkylamino- or piperidinyl- or pyrrolidinylallyl group. The compounds have histamine H.sub.2 -antagonist activity.
REFERENCES:
patent: 4238494 (1980-12-01), Roantree et al.
patent: 4250316 (1981-02-01), Algieri et al.
patent: 4252819 (1981-02-01), Hirata et al.
patent: 4490533 (1984-12-01), Bolhofer et al.
Derwent Abstract 29067E (EP 49173).
Derwent Abstract 20656D (Netherlands 8004967).
Derwent Abstract 55416E (EP 55179).
Derwent Abstract 269K (EP 67436).
Cooper David G.
Sach George S.
Bjorkman Dale A.
Hall Linda E.
Lee Mary C.
Lourie Alan D.
Smith Kline & French Laboratories Limited
LandOfFree
Pyridine derivatives and use as histamine H.sub.2 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine derivatives and use as histamine H.sub.2 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives and use as histamine H.sub.2 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597536